Brineura

Active Ingredient(s): Cerliponase Alfa
FDA Approved: * April 27, 2017
Pharm Company: * BIOMARIN PHARM
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Brineura Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cerliponase Alfa
  • Injection: 30mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Brineura: (1 result)

Sorted by National Drug Code
  • 68135-811 Brineura Intraventricular Kit by Biomarin Pharmaceutical Inc.

Other drugs which contain Cerliponase Alfa or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA